Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada

Table 3

The distribution of patients and overall mortality rates within MELD strata, CP classes and CanWAIT.

(a)

MELD		% Total	Deaths	% Mortality
<10	92	28.8%	7	7.6%
10–19	160	50%	22	13.8%
20–29	46	14.4%	11	23.9%
30–39	15	4.7%	7	46.7%
≥40	7	2.2%	2	28.6%

(b)

CP class		% Total	Deaths	% Mortality
A (5-6)	32	10%	3	9.4%
B (7–9)	145	45.3%	10	6.9%
C (10–15)	143	44.7%	36	25.2%

(c)

CanWAIT status		% Total	Deaths	% Mortality
0	105	32.8%	15	14.3%
1	146	45.6%	20	13.7%
1T	9	2.8%	2	22.2%
2	43	13.4%	7	16.3%
3	4	1.3%	1	25%
3F	1	0.3%	0	0%
4	4	1.3%	2	50%
4F	8	2.5%	2	25%